LISATA THERAPEUTICS, INC. Deferred Revenue
LISATA THERAPEUTICS, INC. (LSTA) had Deferred Revenue of $2.58 million as of 2018-12-31, per its 10-K filed 2019-03-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2019-03-14
- 2018-12-31: Deferred Revenue, Current $2.58M.
- 2017-12-31: Deferred Revenue, Current $2.45M.
- 2017-03-31: Deferred Revenue, Current $5.36M.
- 2016-12-31: Deferred Revenue, Current $5.10M.
| Period end | Deferred Revenue, Current | Deferred Revenue, Current as first filed |
|---|---|---|
| 2018-12-31 | $2.58M 10-K · filed 2019-03-14 | |
| 2017-12-31 | $2.45M 10-K · filed 2019-03-14 | |
| 2017-03-31 | $5.36M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $5.10M 10-Q · filed 2017-05-15 | |
| 2016-09-30 | $5.87M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $7.23M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $5.64M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $5.35M 10-K · filed 2017-03-17 | |
| 2015-09-30 | $5.50M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $4.64M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $5.51M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $4.33M 10-K · filed 2016-03-15 | |
| 2014-09-30 | $3.64M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $2.83M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $2.03M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $1.82M 10-K · filed 2015-03-02 | |
| 2013-09-30 | $1.02M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $362.04K 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $1.82M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $1.47M 10-K · filed 2014-03-13 | |
| 2012-09-30 | $778.09K 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $1.63M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $2.93M 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $1.12M 10-K · filed 2013-03-11 | $2.44M 10-K · filed 2012-03-20 |
| 2011-09-30 | $3.07M 10-Q · filed 2011-11-10 | |
| 2011-06-30 | $4.17M 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $59.36K 8-K · filed 2012-08-15 | $1.71M 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |